Always focusing on tailoring the approach for each patient.
Emergent discipline in medical practice which centers in the leverage of the genomic information from each individual to get a diagnosis and effective treatment.
In the world there are approximately 350 million people (4.6% of the world population) with a genetic disease (also known as rare diseases).
In Mexico this translates to almost 5.8 million people as of today.
Within the multiple medical specialties where genomics has managed breakthroughs in complex disease diagnostics, stand out:
Have you ever wondered how come there are certain people for which some drugs seem to have no effect on them? Or how about those occasions where someone recommends you a drug treatment and you end up feeling worse?
Now We Have Tools To Avoid Those Ailments
Thanks to pharmacogenomics and the vast knowledge reached in pharmacogenetics, as with YOUR genetic and biological profile we can differentiate those active substances with which you’ll have a positive or adverse reaction and even discriminate those that have a longer or shorter period of efficacy.
Pharmacogenetics focus on the study of specific genes variations that modify how our bodies process certain substances such as the active ones found in drugs.
Meanwhile pharmacogenomics centers in the study of the enormous networks between genes, receptors, transporters and enzymes that participate in drug metabolism.
How can IBenefit From This?
The age and concept of “one doses fits all” is approaching its end, thanks to PGx developments that has enabled us to maximize the efficacy of drugs and minimize their toxicity, based on each patient’s genetics.
Furthermore, PGx gives you calm and security by separating you from the statistics of 1.34% of the people who dies due to a fatal adverse drug reaction
7 years of experience and pioneers within the industry
We have helped over 1290 families to find a diagnosis and treatment, thanks to our theranostic approach.